(Q46428656)

22 December 2017

title

Oxymatrine improves TNBS-induced colitis in rats by inhibiting the expression of NF-kappaB p65. (English)

1 reference

22 December 2017

0 references

Heng Fan

1

1 reference

22 December 2017

Rui Chen

2

1 reference

22 December 2017

Lin Shen

3

1 reference

22 December 2017

Jianfang Lv

4

1 reference

22 December 2017

Pengcheng Xiong

5

1 reference

22 December 2017

Zhexing Shou

6

1 reference

22 December 2017

Xiong Zhuang

7

1 reference

22 December 2017

publication date

15 August 2008

1 reference

22 December 2017

Journal of Huazhong University of Science and Technology. Medical Sciences

published in

1 reference

22 December 2017

volume

28

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

415-420

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s11596-008-0409-x

exact match

0 references

cites work

Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FS11596-008-0409-X

Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-008-0409-X

Function and activation of NF-kappa B in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-008-0409-X

Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-008-0409-X

Activation of nuclear factor kappa B inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-008-0409-X

Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Bile synthesis in rat models of inflammatory bowel diseases

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease

1 reference

12 December 2020

Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation

1 reference

12 December 2020

Inflammatory bowel disease: cause and immunobiology

1 reference

12 December 2020

Inflammatory bowel disease: clinical aspects and established and evolving therapies

1 reference

12 December 2020

Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation.

1 reference

12 December 2020

NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein

1 reference

12 December 2020

Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1.

1 reference

12 December 2020

Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium

1 reference

12 December 2020

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms

1 reference

12 December 2020

Anti-interleukin-18 therapy in murine models of inflammatory bowel disease

1 reference

12 December 2020

Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

1 reference

12 December 2020

c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression

1 reference

12 December 2020

NF-kappa B: ten years after

1 reference

12 December 2020

Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis

1 reference

12 December 2020

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

1 reference

12 December 2020

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

12 December 2020

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

1 reference

12 December 2020

NF-kappaB: a key role in inflammatory diseases

1 reference

12 December 2020

Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells

1 reference

12 December 2020

Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease

1 reference

12 December 2020

Critical appraisal of the current practice in murine TNBS-induced colitis

1 reference

12 December 2020

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

12 December 2020

Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.

1 reference

12 December 2020

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

1 reference

12 December 2020

Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice

1 reference

12 December 2020

IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508.

1 reference

12 December 2020

Hapten-induced model of chronic inflammation and ulceration in the rat colon

1 reference

12 December 2020

Inflammatory bowel disease--live transmission

1 reference

12 December 2020

10.1007/S11596-008-0409-X

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017